Posted inEuronext
Sensorion appoints Fred Chereau as CEO as gene therapy programs advance
PARIS: Sensorion, a clinical-stage biotechnology company focused on hearing loss disorders, said Tuesday that Fred Chereau will become chief executive officer effective June 1, 2026, as the company prepares for pivotal…






